In the clinic for March 7, 2022 March 7, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Impedimed, Pathmaker Neurosystems.Read More
In the clinic for March 7, 2022 March 7, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: American Cryostem, Aravive, Atreca, Coherus, Eli Lilly, Equillium, Evofem, Incyte, Mink, Recursion.Read More
In the clinic for March 4, 2022 March 4, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Polyactiva.Read More
In the clinic for March 3, 2022 March 3, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Accustem, Isoray, Prelude.Read More
In the clinic for March 3, 2022 March 3, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ampio, Fulcrum, Greenwich, Sanofi, Tricida.Read More
In the clinic for March 2, 2022 March 2, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actuate, Alx, Ammax, Armaris, Aquestive, Biontech, Bold, Boehringer-Ingelheim, Catalym, Chromadex, Cytokinetics, Durect, Elgan, Genprex, Harm Reduction, Immvira, Inflarx, Innocoll, Inovio, Isa, Intellia, Kalvista, Kintor, Knopp, Lexeo, Mind Medicine, Minerva, Neurogenesis, Newamsterdam, Nicox, Novavax, Pfizer, Projenx, Polypid, Redhill, Regeneron, SAB, Xalud.Read More
In the clinic for Feb. 22-28, 2022 March 1, 2022 Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adamis, Astrazeneca, Bavarian Nordic, Celltrion, Clarity, Daewoong, Daiichi Sankyo, Elpiscience, Innocare, Innovent, Insilico Medicine, Jacobio, Kazia, Lynk, Olipass, Oncocross, Pharmabcine, Polyactiva, Recce, Simcere, Takeda, TFF, Transcenta.Read More
In the clinic for March 1, 2022 March 1, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Baxter, Irhythm.Read More
In the clinic for Feb. 28, 2022 Feb. 28, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biotronik, Envveno.Read More
In the clinic for Feb. 28, 2022 Feb. 28, 2022 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Aptinyx Aquestive, Bavarian Nordic, Celyad, Clarity, Cyclerion, Daewoong, Discgenics, Elpiscience, Evelo, Genmab, Goldfinch, Humacyte, Kazia, Lynk, Lyra, Medivir, Oncocross, PDS, Pliant, Pharmabcine, Seagen, Seelos, Takeda, TG, Transcenta, Zynerba.Read More